Background Available data show that COVID-19 vaccines may be less effective in
immunocompromised populations, who are at increased risk of severe COVID-19 …

Background. Delayed graft function is a frequent complication of kidney transplantation that
requires dialysis in the first week posttransplant. Materials and Methods. We searched for …

COVID-19 is associated with increased morbidity and mortality in transplant recipients.
There are no efficacy data available regarding these patients with any of the available SARS …

According to preliminary data, seroconversion after mRNA SARS‐CoV‐2 vaccination might
be unsatisfactory in Kidney Transplant Recipients (KTRs). However, it is unknown if …

The neutralizing monoclonal antibody combination of tixagevimab/cilgavimab has been
shown to reduce the risk of SARS‐CoV‐2 infection in unvaccinated individuals during the …

Background Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is associated
with a high rate of mortality in patients with ESKD, and vaccination is hoped to prevent …

Poor responses to mRNA COVID-19 vaccine have been reported after 2 vaccine injections
in kidney transplant recipients (KTRs) treated with belatacept. We analyzed the humoral …

Background Immunocompromised patients may be at higher risk of mortality if hospitalised
with Coronavirus Disease 2019 (COVID-19) compared with immunocompetent patients …

Aims Immunocompromised patients have been excluded from studies of SARS-CoV-2
messenger RNA vaccines. The immune response to vaccines against other infectious …

Kidney transplant recipients (KTRs) have been considered as patients at higher risk of
SARS‐CoV‐2‐related disease severity, thus COVID‐19 vaccination was highly …